AGP Executive Report
Last update: 2 hours agoDrug Policy Update: Macau’s government has drafted amendments to its anti-drug law, proposing to add new substances to the drug list, including seven analogues of etomidate (linked to “space oil”), with an urgent legislative process planned. Public Health Alert: The Health Bureau, with ISAF and IAM, ordered the withdrawal and recall of Frisolac Prestige Stage 1 infant formula after lead levels exceeded Macau’s legal limit; authorities expanded testing and set up a “green channel” for paediatric emergency care, reporting no lead-poisoning emergencies among those seeking help. Medicine Safety Watch: ISAF warned residents about “Dermasa,” a topical product allegedly adulterated with Western anaesthetics (lidocaine, tetracaine, prilocaine), urging people not to buy or use it and to surrender any stocks. Hospital Privacy: Starting August 15, Family Medicine Clinics’ telephone appointment system will only accept calls with caller ID to better protect personal data and reduce impersonation risks. Emergency Care Access: SSM said average public emergency department waiting times fell in the first half of 2026, with Category 2 averaging 16 minutes, and noted capacity support from the Macau Medical Centre’s ICU. University Health & Tech: UM launched five new science and technology faculties and two research institutes, including the Faculty of Medicine, plus plans for new postgraduate programmes such as medicinal food and nutrition sciences.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
